Erwin Loh: Can Fiber-Rich Foods Help Reduce Heart Disease Risk in Night Shift Workers?
Erwin Loh, President of Royal Australasian College of Medical Administrators, shared a post on LinkedIn about the recent article by Diana A. Nôga et al, published in European Journal of Epidemiology:
“Working night shifts can increase your odds of developing Coronary Heart Disease (CHD).
But eating a diet high in fiber may help to mitigate this risk, a new study suggests.
Published in the European Journal of Epidemiology, the study reviewed data from more than 220,000 British adults and found that regular night shift workers who ate little fiber in their diets tended to have a higher risk of CHD than their peers who ate more fiber.
The findings suggest that eating a diet with fiber-rich foods – such as whole grains, vegetables, and legumes – could be a simple way for regular night shift workers to reduce their risk of heart disease.”
Title: Night shift work, dietary patterns, and coronary heart disease
Authors: Diana A. Nôga, Elisa M. S. Meth, André P. Pacheco, Jonathan Cedernaes, Pei Xue, Christian Benedict
Read Full Article on European Journal of Epidemiology
Other articles featuring Erwin Loh on Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids